{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:53:59Z","timestamp":1760784839480,"version":"3.44.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.amjcard.2020.04.043","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T12:12:54Z","timestamp":1589371974000},"page":"28-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Effect of Cerebrovascular and\/or Peripheral Artery Disease With or Without Attainment of Lipid Goals on Long-Term Outcomes in Patients With Coronary Artery Disease"],"prefix":"10.1016","volume":"128","author":[{"given":"Ina","family":"Volis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walid","family":"Saliba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronen","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6710-9057","authenticated-orcid":false,"given":"Amnon","family":"Eitan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2391-8397","authenticated-orcid":false,"given":"Barak","family":"Zafrir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2020.04.043_bib0001","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2020.04.043_bib0002","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/CIRCRESAHA.116.303849","article-title":"Epidemiology of peripheral artery disease","volume":"16","author":"Criqui","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.amjcard.2020.04.043_bib0003","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/1358863X10373299","article-title":"Influence of polyvascular disease on cardiovascular event rates. insights from the REACH registry","volume":"15","author":"Su\u00e1rez","year":"2010","journal-title":"Vasc Med"},{"key":"10.1016\/j.amjcard.2020.04.043_bib0004","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/jama.2010.1322","article-title":"Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis","volume":"304","author":"Bhatt","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2020.04.043_bib0005","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/eurheartj\/ehp099","article-title":"Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes","volume":"30","author":"Bhatt","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2020.04.043_bib0006","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1067\/mhj.2003.6","volume":"145","author":"Cotter","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2020.04.043_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2007.02.046","article-title":"Impact of prior peripheral arterial disease and stroke on outcomes of acute coronary syndromes and effect of evidence-based therapies (from the global registry of acute coronary events)","volume":"100","author":"Mukherjee","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2020.04.043_bib0008","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2018-001004","article-title":"Peripheral artery disease and outcomes in patients with acute myocardial infarction","volume":"6","author":"Attar","year":"2019","journal-title":"Open Heart"},{"key":"10.1016\/j.amjcard.2020.04.043_bib0009","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.ijcard.2012.11.033","article-title":"Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT","volume":"168","author":"Inglis","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2020.04.043_bib0010","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.amjcard.2016.12.023","article-title":"Long-term comparative outcomes of patients with peripheral artery disease with and without concomitant coronary artery disease","volume":"119","author":"Chen","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2020.04.043_bib0011","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.ahj.2005.11.005","article-title":"Association of peripheral artery disease with treatment and outcomes in acute coronary syndromes. The global registry of acute coronary events (GRACE)","volume":"151","author":"Froehlich","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2020.04.043_bib0012","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1161\/CIRCOUTCOMES.111.964379","article-title":"Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction","volume":"5","author":"Subherwal","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.amjcard.2020.04.043_bib0013","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.atherosclerosis.2015.11.014","article-title":"Long-term prognostic role of cerebrovascular disease and peripheral arterial disease across the spectrum of acute coronary syndromes","volume":"245","author":"Vagnarelli","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjcard.2020.04.043_bib0014","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2017.02.064","article-title":"Underuse of prevention and lifestyle counseling in patients with peripheral artery disease","volume":"69","author":"Berger","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2020.04.043_bib0015","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/ehjqcco\/qcz048","article-title":"Why have cardiovascular events in peripheral arterial disease patients failed to decline: lessons from a 10-year registry","volume":"5","author":"Ricco","year":"2019","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.amjcard.2020.04.043_bib0016","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/ehjqcco\/qcz037","article-title":"Cardiovascular long-term outcome and prophylactic treatment patterns in peripheral arterial disease in a population-based cohort","volume":"5","author":"Sartipy","year":"2019","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.amjcard.2020.04.043_bib0017","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European atherosclerosis society consensus panel","author":"Bor\u00e9n","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2020.04.043_bib0018","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa1910355","article-title":"A comparison of two LDL cholesterol targets after ischemic stroke","volume":"382","author":"Amarenco","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2020.04.043_bib0019","article-title":"Use of statins in patients with peripheral artery disease","author":"Corrado","year":"2019","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.amjcard.2020.04.043_bib0020","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2020.04.043_bib0021","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2020.04.043_bib0022","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/eurheartj\/ehu071","article-title":"Non-coronary atherosclerosis","volume":"35","author":"Gallino","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2020.04.043_bib0023","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jama.297.11.1197","article-title":"One-year cardiovascular event rates in outpatients with atherothrombosis","volume":"297","author":"Steg","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2020.04.043_bib0024","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.jvs.2016.03.429","article-title":"Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revacularization","volume":"64","author":"Sigvant","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.amjcard.2020.04.043_bib0025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2020.04.043_bib0026","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/CIRCRESAHA.114.303505","article-title":"Pharmacological treatment and current management of peripheral artery disease","volume":"116","author":"Bonaca","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.amjcard.2020.04.043_bib0027","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1161\/CIRCULATIONAHA.118.035432","article-title":"Lipoprotein particle profiles, standard lipids, and peripheral artery disease incidence","volume":"138","author":"Aday","year":"2018","journal-title":"Circulation"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914920304653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914920304653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:33:46Z","timestamp":1757572426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914920304653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":27,"alternative-id":["S0002914920304653"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2020.04.043","relation":{},"ISSN":["0002-9149"],"issn-type":[{"type":"print","value":"0002-9149"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Cerebrovascular and\/or Peripheral Artery Disease With or Without Attainment of Lipid Goals on Long-Term Outcomes in Patients With Coronary Artery Disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2020.04.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}